Recent advances in cell-based therapy for Parkinson disease
Arnar Astradsson1, Oliver Cooper, Angel Vinuela
1NINDS Udall Parkinson's Disease Research Center of Excellence, Harvard University and McLean Hospital, Belmont, Massachusetts 02478, USA.
Neurosurgical Focus
|March 18, 2008
Summary
Cell therapy for Parkinson disease (PD) shows promise, with advances in stem cell-derived dopaminergic neurons offering a potential long-term treatment for synaptic repair.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Therapy
Background:
- Parkinson disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons.
- Current treatments primarily manage symptoms but do not halt disease progression.
- Cell therapy, particularly using dopaminergic neurons, is being explored as a disease-modifying strategy.
Purpose of the Study:
- To review recent advancements in cell therapy for Parkinson disease.
- To compare clinical trials utilizing fetal dopaminergic neurons.
- To discuss alternative cell sources and their development for therapeutic applications.
Main Methods:
- Comparative analysis of clinical trials involving fetal dopaminergic neuron transplantation.
- Review of stem cell research focusing on dopaminergic neuron generation.
- Examination of cell preparation, specification, and immunosuppression strategies.
Main Results:
- Variability in clinical trial outcomes is linked to differences in cell preparation, cell type specification, and immunosuppression protocols.
- Ethical and practical concerns with fetal cell sources drive the development of alternative neuron sources.
- Progress has been made in enriching and purifying stem cell-derived dopaminergic midbrain neurons.
Conclusions:
- Recent progress in cell therapy for Parkinson disease offers hope for a viable long-term treatment.
- Stem cell-derived dopaminergic neurons represent a promising alternative to fetal cells.
- Future strategies aim for effective synaptic repair in Parkinson disease patients.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.